Stocks
Novartis (NVS) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 35.5% | 11.7% | 31.8% | 27.1% | 30.5% | 35.1% | ||
| Changes by years, y/y, % | +21pp | -24pp | +20pp | -5pp | +3pp | +16.4% | |||
Novartis. ROE, %
Novartis. ROE, changes, pp
Novartis (NVS) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 33.5% | 32.5% | 32.5% | 30.3% | 35.1% | 35.1% | |
| Changes by years, y/y, % | -5pp | -6pp | -8pp | +3pp | +2pp | |||
| Changes by quarters, q/q, % | +6pp | -1pp | 0pp | -2pp | +5pp | |||
